UNSPSC 51371806: Pethidine hydrochloride

This classification denotes an opioid receptor agonist with the molecular formula C15H21NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N8E7F7Q170, chemically known as 4-piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester, hydrochloride but more generally known as meperidine hydrochloride, which bears US NIH Compound Identifier 4058. European Medicines Agency schedules Meperidine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03726MIG.

Most nations, for tariff and trade purposes, schedule pethidine hydrochloride under HS 29333300. SMILES: CCOC(=O)C1(CCN(CC1)C)C2CCCCC2.CL.

UNSPSC 51371806 Pethidine hydrochloride is a Commodity code that does not reflect the state and local procurement activity currently tagged under it. The three recent opportunities posted under this code—naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals distribution—involve opioid antagonists, pharmacy benefit program restructuring, and wholesale pharmaceutical supply chains respectively, none of which constitute pethidine hydrochloride procurement. State and local governments appear to be using this code as a catch-all taxonomy marker for pharmaceutical purchasing categories broader than a single active pharmaceutical ingredient, mixing opioid-class drugs, harm-reduction supplies, and pharmacy logistics work in ways that do not align with the Commodity tier's specificity. The issuing bodies across these opportunities span state health agencies (Texas Health and Human Services Commission), county health authorities (Seminole County, Florida), and multi-state cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities in Minnesota and Oregon).

Recent activity shows a geographic spread across Florida, Texas, Minnesota, and Oregon, with no single jurisdiction dominating the code's visible market. The most current opportunity is the Texas HHS Request for Information (RFI) HHS0017013 posted April 3, 2026, soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program—an exploratory phase preceding formal competitive solicitation. Seminole County issued IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: date appears inconsistent with posting). The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC—with awarded vendors effective July 1, 2026. Given the mismatch between the Commodity code's name and the actual procurement scope, this code shows little relevant recent activity for pethidine hydrochloride specifically.